Latest Archimedes Stories

2010-06-25 04:31:00

READING, England, June 25, 2010 /PRNewswire/ -- Archimedes Pharma ("Archimedes"), a leading specialty pharma company, today announced that its lead product, PecFent*, has received a Positive Opinion from the Committee for Human Medicinal Products (CHMP), of the European Medicines Agency (EMA). The CHMP is recommending PecFent, an innovative fentanyl nasal spray, be authorised for marketing in European Union countries for the treatment of breakthrough cancer pain (BTCP) - sudden,...

2010-03-02 01:00:00

READING, England, March 2, 2010 /PRNewswire/ -- - Appoints new Chief Executive Officer to Accelerate Growth of Business - US Commercial Operations to be Established Archimedes Pharma ("Archimedes"), the leading specialty pharma company, today announced that it has raised GBP65 million (approx US$100 million) in new funding. The round was led by new investor Novo Growth Equity, the growth equity fund of Novo A/S, and included participation by major current investor, Warburg...

2010-01-06 10:21:00

"Archimedes-2010" Belgrade, SERBIA, Jan. 6 /PRNewswire-FirstCall/ - Hard to Treat Diseases' (HTDS.PK) (www.htdsmedical.com) Slavica Bio Chem operating subsidiary (www.slavicabiochem.com) is proud to report that IBISS research group is invited, as a representative of Serbia, to participate in the 13th Moscow International Salon of Inventions and Innovation Technologies "Archimedes" that is to be held from March 30 to April 2, 2010 in Moscow, Russia. More information can be found at...

2009-10-26 03:00:00

STOCKHOLM, October 26 /PRNewswire/ -- - Japanese Grant Supports Asian Partnering Programme Pharmalink AB announced today that it has been granted Japanese Patent No 4326696, "Methods and means for treating glomerulonephritis" for its product Nefecon(R) which is being developed to treat IgA nephropathy, a glomerulonephritis leading to end-stage renal disease (ESRD). Counterparts of the patent have been issued for other territories including the EU, US and China. Pharmalink's...

2009-04-29 04:14:00

STOCKHOLM, Sweden, April 29 /PRNewswire/ -- - Results to be Presented at World Congress of Nephrology 2009 Pharmalink AB announced today that it has completed its open Phase II trial evaluating the efficacy and safety of Nefecon(R) in IgA nephropathy, a glomerulonephritis leading to end-stage renal disease. Nefecon is an enteric formulation of a locally acting corticosteroid which downregulates the inflammatory process in the kidneys through suppression of the gut immune...

2005-05-21 17:00:00

BALTIMORE (AP) -- A particle accelerator is being used to reveal the long-lost writings of the Greek mathematician Archimedes, work hidden for centuries after a Christian monk wrote over it in the Middle Ages. Highly focused X-rays produced at the Stanford Linear Accelerator Center were used last week to begin deciphering the parts of the 174-page text that have not yet been revealed. The X-rays cause iron in the hidden ink to glow. "One of the delightful things is we don't know what it's...

Latest Archimedes Reference Libraries

2014-01-02 10:21:51

Geometry is a branch of mathematics that is concerned with questions of shape, size, relative position of figures, and the properties of space. A mathematician who works in the geometry field is called a geometer. Geometry arose independently in numerous early cultures as a body of practical knowledge concerning areas, lengths, and volumes, with elements of a formal mathematical science emerging in the West as early as Thales. By the 3rd century BC, geometry was put into an axiomatic form by...

More Articles (1 articles) »
Word of the Day
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.